# A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.

> **NCT00327392** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 123 (actual)

## Conditions studied

- Procedural Sedation

## Interventions

- **DRUG:** AQUAVAN® (fospropofol disodium) Injection

## Key facts

- **NCT ID:** NCT00327392
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327392, "A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00327392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*